Zhi Sheng Chen
Chief Executive Officer bei WUXI BIOLOGICS (CAYMAN) INC.
Vermögen: 42 Mio $ am 31.03.2024
Profil
Dr. Zhi Sheng Chen ist ein Chief Executive Officer & Executive Director bei Wuxi Biologics (Cayman), Inc. und ein Chairman bei Shanghai Yaoming Haide Biotechnology Co., Ltd. Er ist Mitglied des Board of Directors der International Society for Pharmaceutical Engineering und von Wuxi Biologics (Cayman), Inc. Dr. Chen war zuvor als Chief Operating Officer bei Shanghai Celgen Bio-pharmaceutical Co., Ltd., als Manager bei Merck & Co., Inc., als Director-Process Science & Production bei Eli Lilly Asia, Inc., als Chief Executive Officer bei Kanda Biotech Holdings Ltd. und als Chief Executive Officer & Director bei WuXi AppTec Co., Ltd. tätig. Er diente auch im Vorstand von Eli Lilly & Co. Er erhielt seinen Bachelor-Abschluss von der Tsinghua University und einen Doktortitel von der University of Delaware.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
27.03.2024 | 13 193 017 ( 0,31% ) | 24 Mio $ | 31.03.2024 | |
30.01.2023 | 10 017 926 ( 2,19% ) | 18 Mio $ | 31.03.2024 |
Aktive Positionen von Zhi Sheng Chen
Unternehmen | Position | Beginn |
---|---|---|
WUXI BIOLOGICS (CAYMAN) INC. | Chief Executive Officer | 01.01.2016 |
WUXI XDC CAYMAN INC. | Chairman | 01.12.2020 |
International Society for Pharmaceutical Engineering
International Society for Pharmaceutical Engineering Miscellaneous Commercial ServicesCommercial Services The International Society for Pharmaceutical Engineering is a nonprofit association that focuses on scientific, technical, and regulatory advancement throughout the entire pharmaceutical lifecycle. The non-profit company is based in Tampa, FL. The company engages with all levels of regulators to ensure that their education, training, document development, and interpretation are cutting-edge and focused on enabling the production and supply of therapies and devices with unmatched levels of flow, efficiency, and quality sustainably and at scale. John Bournas has been the CEO of the company since 2015. | Director/Board Member | 07.11.2018 |
Shanghai Yaoming Haide Biotechnology Co., Ltd.
Shanghai Yaoming Haide Biotechnology Co., Ltd. Medical DistributorsDistribution Services Shanghai Yaoming Haide Biotechnology Co., Ltd. is a private company that sells medical equipment and laboratory equipment. The company is based in Shanghai, China and was founded in 2018. | Chairman | - |
WuXi Vaccines Ireland Ltd.
WuXi Vaccines Ireland Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Wuxi Biologics (Cayman), Inc., WuXi Vaccines Ireland Ltd. discovers, develops and manufactures human vaccines. The private company is based in Dundalk, Ireland. The CEO of the Irish company is Jian Dong. | Chairman | - |
Ehemalige bekannte Positionen von Zhi Sheng Chen
Unternehmen | Position | Ende |
---|---|---|
WuXi AppTec (Shanghai) Co. Ltd.
WuXi AppTec (Shanghai) Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of WuXi AppTec Co., Ltd., WuXi AppTec (Shanghai) Co. Ltd. develops and manufactures pharmaceuticals. The private company is based in Shanghai, China. | Corporate Officer/Principal | 01.01.2016 |
Shanghai Celgen Bio-pharmaceutical Co., Ltd.
Shanghai Celgen Bio-pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Celgen Bio-pharmaceutical Co., Ltd. develops and manufactures biopharmaceutical products. The firm's products include Monoclonal Antibody (MAB) used for the treatment of inflammatory conditions such as rheumatoid, juvenile rheumatoid & psoriatic arthritis, ankylosing spondylitis, and plaque psoriasis. The company was founded on November 6, 2000 and is headquartered in Shanghai, China. | Chief Operating Officer | 01.06.2011 |
ELI LILLY AND COMPANY | Director/Board Member | 01.08.2008 |
MERCK & CO., INC. | Corporate Officer/Principal | 01.11.2005 |
░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Zhi Sheng Chen
University of Delaware | Doctorate Degree |
Tsinghua University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 5 |
---|---|
ELI LILLY AND COMPANY | Health Technology |
MERCK & CO., INC. | Health Technology |
WUXI APPTEC CO., LTD. | Health Technology |
WUXI BIOLOGICS (CAYMAN) INC. | Health Technology |
WUXI XDC CAYMAN INC. | Commercial Services |
Private Unternehmen | 8 |
---|---|
Applied Molecular Evolution, Inc.
Applied Molecular Evolution, Inc. Medical/Nursing ServicesHealth Services Applied Molecular Evolution, Inc. provides healthcare support services. It develops novel human biotherapeutics cytokines, hormones, and enzymes. The company was founded in 1989 by Bill Huse and is headquartered in San Diego, CA. | Health Services |
International Society for Pharmaceutical Engineering
International Society for Pharmaceutical Engineering Miscellaneous Commercial ServicesCommercial Services The International Society for Pharmaceutical Engineering is a nonprofit association that focuses on scientific, technical, and regulatory advancement throughout the entire pharmaceutical lifecycle. The non-profit company is based in Tampa, FL. The company engages with all levels of regulators to ensure that their education, training, document development, and interpretation are cutting-edge and focused on enabling the production and supply of therapies and devices with unmatched levels of flow, efficiency, and quality sustainably and at scale. John Bournas has been the CEO of the company since 2015. | Commercial Services |
Shanghai Celgen Bio-pharmaceutical Co., Ltd.
Shanghai Celgen Bio-pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Celgen Bio-pharmaceutical Co., Ltd. develops and manufactures biopharmaceutical products. The firm's products include Monoclonal Antibody (MAB) used for the treatment of inflammatory conditions such as rheumatoid, juvenile rheumatoid & psoriatic arthritis, ankylosing spondylitis, and plaque psoriasis. The company was founded on November 6, 2000 and is headquartered in Shanghai, China. | Health Technology |
Eli Lilly Asia, Inc. | |
Kanda Biotech Holdings Ltd.
Kanda Biotech Holdings Ltd. Financial ConglomeratesFinance Kanda Biotech Holdings Ltd. provides financial services. | Finance |
WuXi AppTec (Shanghai) Co. Ltd.
WuXi AppTec (Shanghai) Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of WuXi AppTec Co., Ltd., WuXi AppTec (Shanghai) Co. Ltd. develops and manufactures pharmaceuticals. The private company is based in Shanghai, China. | Health Technology |
WuXi Vaccines Ireland Ltd.
WuXi Vaccines Ireland Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Wuxi Biologics (Cayman), Inc., WuXi Vaccines Ireland Ltd. discovers, develops and manufactures human vaccines. The private company is based in Dundalk, Ireland. The CEO of the Irish company is Jian Dong. | Commercial Services |
Shanghai Yaoming Haide Biotechnology Co., Ltd.
Shanghai Yaoming Haide Biotechnology Co., Ltd. Medical DistributorsDistribution Services Shanghai Yaoming Haide Biotechnology Co., Ltd. is a private company that sells medical equipment and laboratory equipment. The company is based in Shanghai, China and was founded in 2018. | Distribution Services |